Yes, tirzepatide is a peptide: a lab-made chain of 39 amino acids that activates both the GIP and GLP-1 receptors. It is the active ingredient in Zepbound and Mounjaro. "Research peptide" tirzepatide powder sold online is the same class of molecule in name only: it is not a prescription drug, not tested for you, and not made under the rules that apply to a pharmacy. Start with our tirzepatide guide if you are new to the drug.
Key takeaways
- The label describes tirzepatide as a GIP receptor and GLP-1 receptor agonist, a 39-amino-acid peptide with a C20 fatty diacid chain that extends its half-life to about 5 days.
- The FDA-approved forms are Zepbound and Mounjaro injections. Compounded tirzepatide, prepared by state-licensed 503A pharmacies, is not FDA approved.
- "Research use only" tirzepatide powder is sold outside the drug supply chain, without a prescription, and is flagged by the FDA as a source of concern.
- In SURMOUNT-1, the branded peptide produced a mean weight change of -20.9% at 15 mg over 72 weeks versus -3.1% for placebo.
- A peptide's activity depends on its exact sequence, purity and handling. A vial with no pharmacy label gives you no way to check any of them.
Is tirzepatide a peptide?
It is. A peptide is a short chain of amino acids, the building blocks of proteins. Tirzepatide is a chain of 39 of them, built in a laboratory rather than extracted from anything living. Its sequence is based on the natural gut hormone GIP, with changes that let it also fit the GLP-1 receptor. A fatty acid chain (a C20 fatty diacid) is attached to one of the amino acids. That chain binds to albumin in the blood, which is what keeps the drug circulating for days instead of minutes and makes once-weekly injection possible.
Because it is a peptide, tirzepatide is broken down if swallowed, so it is given by injection under the skin. It is stored cold, at 2 to 8 C, and the branded product can sit unrefrigerated at up to 30 C for up to 21 days. Compounded products follow the storage instructions on the pharmacy's label.
What the tirzepatide peptide does in the body
The two receptors it activates are for incretin hormones, which your gut releases after meals. Turning them on increases insulin release when blood sugar is high, lowers glucagon, slows stomach emptying and reduces appetite. Those effects are what the trials measured. Our how tirzepatide works page walks through the mechanism; the results are below.
Check your GLP-1 eligibility
Use our free BMI Calculator to see if you may qualify for provider-reviewed GLP-1 therapy.
Try the BMI Calculator →| Trial | Population | Length | Tirzepatide | Comparator |
|---|---|---|---|---|
| SURMOUNT-1 | Obesity or overweight, no diabetes | 72 weeks | -15.0% (5 mg), -19.5% (10 mg), -20.9% (15 mg) weight | -3.1% placebo |
| SURMOUNT-5 | Obesity, no diabetes | 72 weeks | -20.2% weight | -13.7% semaglutide |
| SURPASS-2 | Type 2 diabetes | 40 weeks | A1c -2.01 to -2.30 points; weight -7.6 to -11.2 kg | A1c -1.86; weight -5.7 kg (semaglutide 1 mg) |
Source: PubMed entries for SURMOUNT-1 (35658024), SURMOUNT-5 (40353578) and SURPASS-2 (34170647). All three trials used the branded injectable.
Tirzepatide research peptide vs prescription tirzepatide
Search for "tirzepatide powder" and you will find vials labeled "for research use only" or "not for human consumption" sold without a prescription. Here is how those differ from a prescription.
| Feature | Zepbound or Mounjaro | Compounded tirzepatide (state-licensed 503A pharmacy) | "Research peptide" powder |
|---|---|---|---|
| Prescription required | Yes | Yes | No |
| FDA status | FDA approved | Not FDA approved | Not a drug at all; labeled not for human use |
| Who oversees it | FDA | State board of pharmacy | No one, for human use |
| Made for | All patients, from an approved application | One named patient, from a prescription | Laboratory research |
| Clinician involved | Yes | Yes, a licensed prescriber | No |
| Concentration on the label | Fixed doses, 2.5 to 15 mg | Stated on the pharmacy label (for example 10 mg/mL) | Milligrams of powder; you mix it yourself with no oversight |
| Sterility and beyond-use date | Set by the manufacturer | Set by the pharmacy label | Unknown |
Source: FDA, Compounding and the FDA: Questions and Answers; FDA, Concerns with Unapproved GLP-1 Drugs Used for Weight Loss; Zepbound prescribing information.
The FDA's concern page is blunt: products sold outside the legal supply chain may contain the wrong ingredient, the wrong amount, or contaminants, and the agency cannot verify what is in them. A certificate of analysis posted on a website is a document about a batch of powder, not proof of what is in the vial that reaches you. We cover the practical risks on our gray market tirzepatide page.
Powdered tirzepatide: what "reconstitution" means
Some compounded tirzepatide is dispensed as a powder that the pharmacy or patient mixes with bacteriostatic water before use, and a vial of research powder requires the same step. When a licensed pharmacy does it, the label tells you the resulting concentration. When you do it at home with an unlabeled vial, the concentration is whatever your math says it is, and a mistake is invisible.
The math itself is simple only when the concentration is known. At 10 mg/mL as an example, 2.5 mg is 0.25 mL or 25 units on a U-100 insulin syringe; 5 mg is 50 units; 7.5 mg is 75 units; 10 mg is 100 units; 12.5 mg is 125 units; 15 mg is 150 units. At 5 mg/mL those unit counts double; at 20 mg/mL they halve. The concentration on the vial label controls, and you should confirm it with the pharmacy. Our how to mix tirzepatide powder page goes step by step.
Why the sequence matters
A peptide is only tirzepatide if all 39 amino acids are in the right order with the fatty acid chain attached at the right spot. Synthesis errors produce chains that are almost right, and "almost right" peptides may bind the receptors weakly or not at all. Pharmaceutical manufacturers and licensed compounding pharmacies test identity and purity of the ingredient they use. A research vendor may claim to, but no regulator checks that claim on behalf of a person injecting it.
What this means for compounded tirzepatide
FormBlends offers compounded tirzepatide, not research peptides. It is prescribed by independent, state-licensed clinicians of Recess MD LLC and prepared by state-licensed 503A compounding pharmacies (Greenwich RX in Texas, The DrugStore on East State in Ohio, and Chemistry Rx in Pennsylvania), then shipped cold with injection supplies included. It costs $149 for the first month and $239 a month after that, at any dose. Compounded tirzepatide is not FDA approved and is not interchangeable with Zepbound or Mounjaro. See the tirzepatide product page or begin the assessment.
Frequently Asked Questions
Is tirzepatide a peptide?
Yes. It is a synthetic peptide of 39 amino acids with an attached C20 fatty diacid chain, described on the Zepbound and Mounjaro labels as a GIP receptor and GLP-1 receptor agonist. It is injected because peptides are digested when swallowed.
What is a tirzepatide research peptide?
It is tirzepatide powder sold "for research use only" without a prescription, outside the pharmacy system. It is not a medicine, is not made or checked for human use, and is one of the unapproved GLP-1 products the FDA warns about.
Can I buy tirzepatide powder and use it myself?
Not as a lawful medication. Tirzepatide for a person always requires a prescription, and a licensed pharmacy or manufacturer must prepare it. Mixing unlabeled powder at home leaves you with no verified concentration and no way to know what you injected.
Is powdered tirzepatide from a compounding pharmacy different?
Yes. A state-licensed 503A pharmacy dispenses it under a prescription with your name, the drug, the concentration after mixing, and a beyond-use date on the label. That label is the difference between a compounded medication and a research vial.
How much weight loss does the tirzepatide peptide produce?
In SURMOUNT-1, the branded injectable produced mean weight changes of -15.0%, -19.5% and -20.9% at 5, 10 and 15 mg over 72 weeks, versus -3.1% on placebo. Those results apply to the tested product, not to compounded or research vials.
Sources
- Zepbound prescribing information, DailyMed, revised 08/2026.
- Mounjaro prescribing information, DailyMed, revised 08/2026.
- Compounding and the FDA: Questions and Answers, U.S. Food and Drug Administration.
- FDA's Concerns with Unapproved GLP-1 Drugs Used for Weight Loss, U.S. Food and Drug Administration.
- Tirzepatide Once Weekly for the Treatment of Obesity (SURMOUNT-1), Jastreboff et al., New England Journal of Medicine, 2022.
- Tirzepatide as Compared with Semaglutide for the Treatment of Obesity (SURMOUNT-5), Aronne et al., New England Journal of Medicine, 2025.
- Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes (SURPASS-2), Frias et al., New England Journal of Medicine, 2021.
Next steps
If you are weighing sources, read is compounded tirzepatide safe next. Browse the tirzepatide hub for every other tirzepatide question. Talk to a licensed clinician before starting or changing any medication. Compounded tirzepatide is not FDA approved and is not interchangeable with Zepbound or Mounjaro; a licensed provider decides whether it is appropriate for you.
See your options in about 2 minutes
Take the free quiz and see what fits you. Quick, private, and no commitment to continue.
See my options →